LI Xiao Ying, LI Ying, ZHANG Yao, KANG Wan Li, ZHAO Li Ping, DING Peng Ju, DAI Wen Tao, HUANG Hai Rong, HUANG Yan Feng, LI Wei Min. The Epidemiological Characteristics of Beijing Lineage Mycobacterium tuberculosis from a National Referral Center in China[J]. Biomedical and Environmental Sciences, 2015, 28(7): 539-543. doi: 10.3967/bes2015.077
Citation:
|
LI Xiao Ying, LI Ying, ZHANG Yao, KANG Wan Li, ZHAO Li Ping, DING Peng Ju, DAI Wen Tao, HUANG Hai Rong, HUANG Yan Feng, LI Wei Min. The Epidemiological Characteristics of Beijing Lineage Mycobacterium tuberculosis from a National Referral Center in China[J]. Biomedical and Environmental Sciences, 2015, 28(7): 539-543. doi: 10.3967/bes2015.077
|
The Epidemiological Characteristics of Beijing Lineage Mycobacterium tuberculosis from a National Referral Center in China
-
Tianjin Children’s Hospital, Tianjin 300074, China
-
Zhejiang Provincial Key Laboratory for Technology&Application of Model 0rganisms, School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China
-
Clinical Epidemiology Unit, Peking Union Medical Col ege, Beijing 101149, China
-
Department of Epidemiology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China
-
National Tuberculosis Clinical Lab of China, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China
-
Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China
-
Division of Infectious Disease and Gastroenterology, Children’s Hospital, Chongqing Medical University, Chongqing 400014, China
Funds:
This study was supported by the National Natural Science Foundation of China(81273144)%Beijing Natural Science Foundation Program and Scientific Research Key Program of Beijing Municipal Commission of Education(KZ201510025024)%Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support(ZYLX201304)